BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schrover R, Evans K, Giugliani R, Noble I, Bhattacharya K. Minimal clinically important difference for the 6-min walk test: literature review and application to Morquio A syndrome. Orphanet J Rare Dis 2017;12:78. [PMID: 28441951 DOI: 10.1186/s13023-017-0633-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Keles MN, Elbasan B, Apaydin U, Aribas Z, Bakirtas A, Kokturk N. Effects of inspiratory muscle training in children with cerebral palsy: a randomized controlled trial. Braz J Phys Ther 2018;22:493-501. [PMID: 29636305 DOI: 10.1016/j.bjpt.2018.03.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
2 Chotiyarnwong C, Nair K, Angelini L, Buckley E, Mazza C, Heyes D, Ramiz R, Baster K, Ismail A, Das J, Ali A, Lindert R, Sharrack B, Price S, Paling D. Effect of remote ischaemic preconditioning on walking in people with multiple sclerosis: double-blind randomised controlled trial. BMJ Neurol Open 2020;2:e000022. [PMID: 33681776 DOI: 10.1136/bmjno-2019-000022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Beretta E, Storm FA, Strazzer S, Frascarelli F, Petrarca M, Colazza A, Cordone G, Biffi E, Morganti R, Maghini C, Piccinini L, Reni G, Castelli E. Effect of Robot-Assisted Gait Training in a Large Population of Children With Motor Impairment Due to Cerebral Palsy or Acquired Brain Injury. Arch Phys Med Rehabil 2020;101:106-12. [PMID: 31562873 DOI: 10.1016/j.apmr.2019.08.479] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
4 Alma H, de Jong C, Tsiligianni I, Sanderman R, Kocks J, van der Molen T. Clinically relevant differences in COPD health status: systematic review and triangulation. Eur Respir J 2018;52:1800412. [PMID: 30139774 DOI: 10.1183/13993003.00412-2018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
5 Bohingamu Mudiyanselage S, Stevens J, Watts JJ, Toscano J, Kotowicz MA, Steinfort CL, Bell J, Byrnes J, Bruce S, Carter S, Hunter C, Barrand C, Hayles R. Personalised telehealth intervention for chronic disease management: A pilot randomised controlled trial. J Telemed Telecare 2019;25:343-52. [PMID: 29793387 DOI: 10.1177/1357633X18775850] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Karaa A, Haas R, Goldstein A, Vockley J, Cohen BH. A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy. J Cachexia Sarcopenia Muscle 2020;11:909-18. [PMID: 32096613 DOI: 10.1002/jcsm.12559] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Jones SA, Marsden D, Koutsoukos T, Sniadecki J, Tylee K, Phillippo S, Kakkis E. Retrospective chart review of urinary glycosaminoglycan excretion and long-term clinical outcomes of enzyme replacement therapy in patients with mucopolysaccharidoses. Mol Genet Metab 2020;130:255-61. [PMID: 32563631 DOI: 10.1016/j.ymgme.2020.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Lee SH, Kim HY, Cho T, Kim H, Ko JM. Clinical characteristics and effects of enzyme replacement therapy with elosulfase alfa in Korean patients with mucopolysaccharidosis type IVA. Molecular Genetics and Metabolism Reports 2022;31:100869. [DOI: 10.1016/j.ymgmr.2022.100869] [Reference Citation Analysis]
9 Moisan L, Iannuzzi D, Maranda B, Campeau PM, Mitchell JJ. Clinical characteristics of patients from Quebec, Canada, with Morquio A syndrome: a longitudinal observational study. Orphanet J Rare Dis 2020;15:270. [PMID: 32993725 DOI: 10.1186/s13023-020-01545-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Storm FA, Petrarca M, Beretta E, Strazzer S, Piccinini L, Maghini C, Panzeri D, Corbetta C, Morganti R, Reni G, Castelli E, Frascarelli F, Colazza A, Cordone G, Biffi E. Minimum Clinically Important Difference of Gross Motor Function and Gait Endurance in Children with Motor Impairment: A Comparison of Distribution-Based Approaches. Biomed Res Int 2020;2020:2794036. [PMID: 32509855 DOI: 10.1155/2020/2794036] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
11 Pilkey J, Pedersen A, Tam JW, Malik A, Wong J. The Use of Intranasal Fentanyl for the Palliation of Incident Dyspnea in Advanced Congestive Heart Failure: A Pilot Study. J Palliat Care 2019;34:96-102. [DOI: 10.1177/0825859718777343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Sawamoto K, Stapleton M, Alméciga-Díaz CJ, Espejo-Mojica AJ, Losada JC, Suarez DA, Tomatsu S. Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments. Drugs 2019;79:1103-34. [PMID: 31209777 DOI: 10.1007/s40265-019-01147-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 11.3] [Reference Citation Analysis]
13 Parini R, Deodato F. Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations. Int J Mol Sci 2020;21:E2975. [PMID: 32340185 DOI: 10.3390/ijms21082975] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
14 Phillips D, Tomazos IC, Moseley S, L'Italien G, Gomes da Silva H, Lerma Lara S. Reliability and Validity of the 6-Minute Walk Test in Hypophosphatasia. JBMR Plus 2019;3:e10131. [PMID: 31346563 DOI: 10.1002/jbm4.10131] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
15 Dornelles AD, Junges APP, Pereira TV, Krug BC, Gonçalves CBT, Llerena JC Jr, Kishnani PS, de Oliveira HA Jr, Schwartz IVD. A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease. J Clin Med 2021;10:4828. [PMID: 34768348 DOI: 10.3390/jcm10214828] [Reference Citation Analysis]
16 Diaz GA, Schulze A, McNutt MC, Leão-Teles E, Merritt JL 2nd, Enns GM, Batzios S, Bannick A, Zori RT, Sloan LS, Potts SL, Bubb G, Quinn AG. Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency. J Inherit Metab Dis 2021;44:847-56. [PMID: 33325055 DOI: 10.1002/jimd.12343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tillin T, Tuson C, Sowa B, Chattopadhyay K, Sattar N, Welsh P, Roberts I, Ebrahim S, Kinra S, Hughes A, Chaturvedi N. Yoga and Cardiovascular Health Trial (YACHT): a UK-based randomised mechanistic study of a yoga intervention plus usual care versus usual care alone following an acute coronary event. BMJ Open 2019;9:e030119. [PMID: 31685500 DOI: 10.1136/bmjopen-2019-030119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Sampayo-Cordero M, Miguel-Huguet B, Malfettone A, Pérez-García JM, Llombart-Cussac A, Cortés J, Pardo A, Pérez-López J. The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: "The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis". Front Mol Biosci 2021;8:690615. [PMID: 34239895 DOI: 10.3389/fmolb.2021.690615] [Reference Citation Analysis]
19 Shapiro EG, Eisengart JB. The natural history of neurocognition in MPS disorders: A review. Mol Genet Metab 2021;133:8-34. [PMID: 33741271 DOI: 10.1016/j.ymgme.2021.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
20 Kim ST, Oh DW, Lee JH. Initial Evidence on the Impact of Performance-Based Treadmill Training on Pulmonary Function and Physical Performance in a Child with Bronchopulmonary Dysplasia: Single-Subject Experimental Study. Phys Occup Ther Pediatr 2020;40:384-94. [PMID: 31865839 DOI: 10.1080/01942638.2019.1705455] [Reference Citation Analysis]
21 Akyol MU, Alden TD, Amartino H, Ashworth J, Belani K, Berger KI, Borgo A, Braunlin E, Eto Y, Gold JI, Jester A, Jones SA, Karsli C, Mackenzie W, Marinho DR, McFadyen A, McGill J, Mitchell JJ, Muenzer J, Okuyama T, Orchard PJ, Stevens B, Thomas S, Walker R, Wynn R, Giugliani R, Harmatz P, Hendriksz C, Scarpa M; MPS Consensus Programme Steering Committee., MPS Consensus Programme Co-Chairs. Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance. Orphanet J Rare Dis 2019;14:137. [PMID: 31196221 DOI: 10.1186/s13023-019-1074-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
22 Reneaud N, Gerus P, Guérin O, Garda M, Piche E, Chorin F, Zory R. 6MWT on a new self-paced treadmill system compared with overground. Gait Posture 2021;92:8-14. [PMID: 34801954 DOI: 10.1016/j.gaitpost.2021.11.015] [Reference Citation Analysis]
23 Denissen S, De Cock A, Meurrens T, Vleugels L, Van Remoortel A, Gebara B, D'Haeseleer M, D'Hooghe MB, Van Schependom J, Nagels G. The Impact of Cognitive Dysfunction on Locomotor Rehabilitation Potential in Multiple Sclerosis. J Cent Nerv Syst Dis 2019;11:1179573519884041. [PMID: 31723322 DOI: 10.1177/1179573519884041] [Reference Citation Analysis]